Dr Linda M Harris, MD | |
100 High St, Dept Of Surgery, Buffalo, NY 14203-1126 | |
(716) 859-4225 | |
(716) 859-4222 |
Full Name | Dr Linda M Harris |
---|---|
Gender | Female |
Speciality | Vascular Surgery |
Experience | 37 Years |
Location | 100 High St, Buffalo, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053339515 | NPI | - | NPPES |
01583155 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0129X | Surgery - Vascular Surgery | 178098 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaleida Health | Buffalo, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University At Buffalo Surgeons Inc | 4183612799 | 26 |
News Archive
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Fractured teeth, neck injuries and abrasions in the mouth, also known as sports-related dental injuries, are ever present among athletes.
The Jeffrey Modell Foundation today announced the opening of a new center at Johns Hopkins Children's Center dedicated to the early diagnosis and appropriate treatment of children with primary immunodeficiency, a group of potentially fatal conditions in which the immune system malfunctions or is missing.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 9 days ago
Entity Name | University At Buffalo Surgeons Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508898305 PECOS PAC ID: 4183612799 Enrollment ID: O20040503001532 |
News Archive
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Fractured teeth, neck injuries and abrasions in the mouth, also known as sports-related dental injuries, are ever present among athletes.
The Jeffrey Modell Foundation today announced the opening of a new center at Johns Hopkins Children's Center dedicated to the early diagnosis and appropriate treatment of children with primary immunodeficiency, a group of potentially fatal conditions in which the immune system malfunctions or is missing.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 9 days ago
Entity Name | Vascular-interventional Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881735496 PECOS PAC ID: 2961557590 Enrollment ID: O20111108000886 |
News Archive
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Fractured teeth, neck injuries and abrasions in the mouth, also known as sports-related dental injuries, are ever present among athletes.
The Jeffrey Modell Foundation today announced the opening of a new center at Johns Hopkins Children's Center dedicated to the early diagnosis and appropriate treatment of children with primary immunodeficiency, a group of potentially fatal conditions in which the immune system malfunctions or is missing.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Linda M Harris, MD Po Box 8000 Dept 313, University At Buffalo Surgeons Inc, Buffalo, NY 14267-0002 Ph: (716) 888-4889 | Dr Linda M Harris, MD 100 High St, Dept Of Surgery, Buffalo, NY 14203-1126 Ph: (716) 859-4225 |
News Archive
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Fractured teeth, neck injuries and abrasions in the mouth, also known as sports-related dental injuries, are ever present among athletes.
The Jeffrey Modell Foundation today announced the opening of a new center at Johns Hopkins Children's Center dedicated to the early diagnosis and appropriate treatment of children with primary immunodeficiency, a group of potentially fatal conditions in which the immune system malfunctions or is missing.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 9 days ago
Paul M Anain, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2121 Main Street, Suite 316, Buffalo, NY 14214 Phone: 716-837-2400 Fax: 716-837-3860 | |
Dr. James K Lukan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 462 Grider St, Dept Of Surgery, Buffalo, NY 14215 Phone: 716-898-5186 Fax: 716-898-3194 | |
Kristen Calabro, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1001 Main Street, Conventus 5th Floor, Buffalo, NY 14202 Phone: 716-323-0638 | |
John M Kane Iii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-2320 | |
Paul Tomljanovich, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-4341 | |
David Michael Cohan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-8646 |